Firms Form Partnership to Develop Software

Simulations Plus Inc. has formed a joint venture with Absorption Systems LP of Exton, Pa.

Lancaster-based Simulations Plus (SIMU on Nasdaq) is a developer of drug simulation software for the pharmaceutical industry. Absorption Systems is a research facility.

Under the joint venture agreement, they will work together on computer programs to test new drugs for the way human bodies absorb, metabolize and eliminate compounds after they are swallowed.

The company said the purpose of the computer-based studies is to eliminate much of the time, expense and animal rights problems common to new drug testing, with the ultimate goal of expediting the release of new pharmaceutical agents.